Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01003080 · ClinicalTrials.gov registry record · NA
Unipolar vs. Bipolar Hemostasis in Total Knee Arthroplasty: A Prospective Randomized Trial
A NA study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 111
- Enrollment target
NCT01003080 is a NA study that has completed, run by Montefiore Medical Center. The registered enrollment target is 111 participants.
The verdict
NCT01003080, a NA study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 111 participants
- Enrollment target
Study Summary
The use of Aquamantys during total knee arthroplasty will reduce drain output and the necessity for blood transfusions.
Interventions
- DEVICE Aquamantys Device
- OTHER Standard of care treatment for hemostasis during a total knee arthroplasty.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2009-08 |
| Est. Completion | 2010-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01003080
The ClinicalTrials.gov registry entry for NCT01003080 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Aquamantys Device is the first listed.
NCT01003080 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01003080 about?
NCT01003080 is a clinical study titled "Unipolar vs. Bipolar Hemostasis in Total Knee Arthroplasty: A Prospective Randomized Trial". The use of Aquamantys during total knee arthroplasty will reduce drain output and the necessity for blood transfusions.
What is the current status of trial NCT01003080?
This trial is currently completed. It is a NA study. The enrollment target is 111 participants. The study started on 2009-08. Estimated completion is 2010-04.
What interventions are being tested in trial NCT01003080?
The interventions under investigation include: Aquamantys Device (DEVICE), Standard of care treatment for hemostasis during a total knee arthroplasty. (OTHER).
Who is sponsoring clinical trial NCT01003080?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.